Methods
Between August 1997 and September 2006, 78 patients were selected for transcatheter closure of moderate to large PDA (minimal PDA diameter ≥0.25 cm). Two patients were excluded after aortography documented the PDA as too large to close in 1 case and too small for percutaneous closure in the other case. Therefore, 76 patients underwent percutaneous closure of large PDA. The age at the time of procedure ranged from 21 days to 46 years (mean: 5.7±9.3 years) and the weight ranged from 3.3 to 62 kg (mean: 16.8±15.3 kg). The minimum diameter of the PDA ranged from 2.5 to 8.0 mm (mean: 4.1±0.9 mm). The pulmonary blood flow to systemic blood flow ratio obtained by the Fick method ranged from 1.5 to 4.8, with a mean value of 2.4±0.5. Twenty-one patients (27%) were on medication to reduce cardiac preload. Between August 1997 and October 2002, 21 patients received at least one 0.052-inch coil and achieved complete closure with a multiple coil strategy for large PDA. In mid-2001 we started using the ADO and data from 55 patients were collected till September 2006. Based on PDA size and morphology, duct occlusion was achieved by 0.052-inch Gianturco coil (21 patients, group I) or ADO (55 patients, group II). After informed consent from adult patients or the child's parents, cardiac catheterization was performed under heavy sedation for children and local anesthesia. All patients underwent right and left heart catheterization. The PDA closure protocol has been well described. [3] [4] [5] [6] [7] Briefly, after hemodynamic study and data collection, descending aortography in the right anterior oblique and lateral views was performed and the PDA shape and size were analyzed and classified according to Krichenko et al: 8 49 patients had type A, 21 had type C, 1 had type D and 5 had type E. All patients had typical continuous murmur.
In the coil method, a single coil was used for the first implantation and if necessary 2 coils were implanted simultaneously (Fig 1) . We chose the coil diameter to be 2-2.5-fold wider than the narrowest duct diameter and long enough to produce 3-4 loops. During implantation, the Gianturco coils maintain their tightly wound loop size and configuration, and if necessary a second coil is used for shunt closure. Echocardiography and fluoroscopy are performed to ensure the coils are in situ and the PDA shunt closed. Color Doppler echocardiography (VingMed Ultrasound system Five, GE Corp, Stockton, CA, USA) is used to check for residual and if there is persistent flow with a diameter larger than 1 mm, a coil with a diameter 1.5-2-fold times wider than the narrowest duct diameter is used. Closure of PDA was considered successful if no residual shunt or trivial residual shunt (<1 mm color Doppler jet) was found by echocardiography 15 min after implantation.
For the ADO technique, we chose the device size to be 2 mm larger than the minimal duct diameter measured by aortography. The device was deployed via the right heart through the pulmonary artery (PA) -descending aorta route (Fig 2) . The technique of transcatheter closure has been described in detail. [4] [5] [6] In brief, after a complete saturation and hemodynamic study, biplane anteroposterior and lateral descending aortography was performed to evaluate the size and anatomy of the PDA. A 0.038-inch exchange guidewire is placed across the ductus from the PA via an end-hole catheter. Over the wire, a 6, 7 or 8Fr long sheath (AGA Medical Corporation) is introduced from the femoral vein through the duct into the aorta. An ADO at least 2 mm larger than the narrowest diameter of the duct is chosen. We open the disk in the distal thoracic aorta in order to avoid possible damage to the aortic wall by the protrusion of the small metal disk. Once in position, the disk is pulled gently against the orifice of the PDA and with gentle tension on the delivery cable, the sheath is pulled back to deploy the pulmonary end of the device. With the device still attached to the cable, transthoracic color Doppler echocardiography and descending aortography are performed to confirm proper device position and exclude left PA or aortic obstruction. Once in the optimal position, the ADO is released by counterclockwise rotation of the delivery cable. Repeat echocardiography is performed to check for residual shunt 15 min after the release of the ADO. Prophylactic cefazolin and gentamicin were routinely administered during the procedure. All patients were sent home 2 days after transcatheter PDA occlusion with no medication. Endocarditis prophylaxis was discontinued at the 6-month follow-up visit if the ductus was completely closed. Procedural and fluoroscopy time were calculated at the end of the procedure. Clinical and echocardiographic follow-up were routinely performed at discharge, after 1, 6, and 12 months, and then annually thereafter if any residual shunt persisted. PDA was considered fully occluded if no residual shunt was seen on echocardiography, and recanalization was considered to have occurred if any duct shunt was detected in a patient with a previously documented complete occlusion.
Results are expressed as mean ± SD; and range with median. Statistical analysis was performed using the unpaired Student's t-test and the Fisher exact test. Significance was defined as P<0.05.
Results
Transcatheter closure was performed in all but 2 patients (97.7%); in 1999, a 48-kg, 16-year-old girl was referred for PDA closure but she had a tubular PDA that measured approximately 6 mm, which was judged as impossible for coil closure. The other exclusion was a baby aged 1-month-old, weighing 3.3 kg in severe congestive heart failure. Angiography at the time of intended PDA occlusion revealed an 8-mm tubular PDA, which was too large and unsuitable for closure with an 8/10-mm ADO because of the small aortic isthmus. She was also referred for surgical repair. Clinical, hemodynamic, and angiographic data at procedure of the remaining patients are listed in Table 1 . The results according to the therapeutic option are reported in Table 2 . There were 3 patients in group I who had failed implantation of coils. The first was a 55-kg, 20-year-old man who had coil embolization to the right PA and was referred for surgical removal and closure. Another 9.8-kg, 10-month-old infant had hemolysis and late coil migration to the left PA and was later referred for surgery. The last patient was a 3-yearold girl with coil embolization to the left PA. We retrieved the coil by a snare and she was referred for surgical closure on her family's decision. There was no significant difference in the age distribution of the 2 groups (4.4±8. We also compared the results of using 0.052-inch coils or the ADO device for PDAs ≥2.5 mm or <4 mm. The results showed no difference in the successful deployment and occlusion rates in our patient population; the complication of migration was also statistically not significant in this study ( Table 3) .
Discussion
Since the first study of percutaneous PDA closure using the Gianturco coil reported by Cambier et al in 1992, 2 nonsurgical closure of PDA has been widely accepted as an alternative to surgical closure. Though the results are encouraging in small PDA, it is still a challenging task for large PDA closure, with occasional procedural failures and residual shunt. The most challenging task is in small children with a moderate to large PDA (≥2.5 mm) because inappropriate implantation or migration of the coil to the pulmonary or peripheral systemic arteries can happen. Before the introduction of the ADO device, we used the large 0.052-inch coils combined with a multiple coil strategy for PDA closure. 8, 9 It is an effective method, but also revealed significant complications with hemolysis and/or embolization, 10,11 which required longer hospital stay; even second catheterization for further coil placement. In our study, the failure rate was significant in the coil group (16.6% vs 0%; P<0.05). Device embolization was also significantly different between the 2 groups (P<0.05), although hemolytic complications were not significantly different (P>0.05) ( Table 2) .
Many devices were developed for large PDA closure, including the Sideris buttoned device (Custom Medical Devices, Amarillo, TX, USA), or the Gianturco-Grifka Vascular Occlusion device (Cook Inc, Bloomington, IN, USA). 12, 13 However, the results were not promising. Recently, the ADO device has proved to be highly effective in several studies, [4] [5] [6] the implantation method is easy and has several favorable features, including a relatively small delivery sheath (6-8Fr), a design that affords the possibility of retrieval and of repositioning before release of the occluder, and high rates of closure. In our study, the ADO method had a significantly higher closure rate immediately and at 1 day after implantation, also with lower complications (Table 2) . Consequently, we believe the ADO has definite advantages over multiple 0.052-inch coils for closing large PDAs. We also found the multiple coils approach more time-consuming with a significantly prolonged procedure time (Table 1) (P<0.05). The multiple coil approach is more technically challenging and has a not negligible incidence of procedural failures and complications. Accordingly, we believe the ADO device approach is the first option for closure of moderate to large PDA, whenever the local anatomy and PDA shape allow its use.
There are some reports regarding the use of 0.052-inch coils for PDA occlusion. In a study by Tomita et al, they also used the 0.052-inch coil and complete closure with other smaller sized coils, and their results showed a successful outcome for PDA around 3 mm in size was significant differently than that for a PDA larger than 4 mm. 14 We analyzed our data from selected patients with a PDA ≥2.5 mm or <4 mm, Tables 1,2. and there were no significant differences in successful closure rate or complications between 0.052-inch coils and the ADO device (Table 3) . However, there was 1 case of a migrating coil, which was retrieved surgically. Kobayashi et al also reported that coil migration in children was not uncommon. 15 Though we did not have any cases of hemolysis using coil occlusion for PDA ≥2.5 mm or <4 mm, the complication of hemolysis was more frequent in the coil group and is an unacceptable outcome. Hence, the use of 0.052-inch coils for closure of moderate to large PDA should be carefully considered on the basis of the angiographic findings and the availability of an experienced interventionist. Overall, the PDA occlusion rate in this study was as high as 96.1% after 1 month and over the mid-term follow-up. After the procedure, a trend toward an earlier complete PDA closure after ADO implantation was recorded, with a significant difference between the groups ( Table 2) . Though, despite the multiple coil approach being cheaper than the ADO device approach, 16 we found it appropriate to use the ADO approach for large PDA closure. However, 0.052-inch coils might still be used for PDA around 3 mm and appropriate morphology. Further study should be conducted to clarify the safety and efficacy of large PDA closure. In conclusion, introduction of the ADO device decreased eventful deployment during percutaneous occlusion of PDA ≥2.5 mm, and contributed to better outcomes of occlusion of PDA ≥2.5 mm.
